COVID-19 replicating RNA vaccine has robust response in nonhuman primates
A replicating RNA vaccine, formulated with a lipid-based nanoparticle emulsion that goes by the acronym LION, produces antibodies against the COVID-19 coronavirus in mice and primates with a single immunization. These antibodies potently neutralize the virus. The effects occurred within two weeks after administration through injection into a muscle. The level of antibodies generated was…
Details